Reduced-intensity allogenic transplantation for children and adolescents with Philadelphia chromosome-positive acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Reduced-intensity allogenic transplantation for children and adolescents with Philadelphia chromosome-positive acute lymphoblastic leukemia

Published:2023-11-25 Issue: Volume: Page:
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Ishida Hisashi,Arakawa Yuki,Hasegawa Daiichiro,Usami Ikuya,Hashii Yoshiko,Arai Yasuyuki,Nishiwaki Satoshi,Keino Dai,Kato Keisuke,Sato Maho,Yoshida Nao,Ozawa Yukiyasu,Okada Keiko,Hidaka Moe,Yuza Yuki,Tanaka Masatsugu,Watanabe Kenichiro,Takita Junko,Kosaka Yoshiyuki,Fujita Naoto,Tanaka Junji,Sato Atsushi,Atsuta Yoshiko,Imamura Toshihiko^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-023-05557-z.pdf

Reference38 articles.

1. Pui C-H, Relling MV, Downing JR (2004) Acute lymphoblastic leukemia. New England J Med 350:1535–1548. https://doi.org/10.1056/NEJMra023001

2. Aricò M, Valsecchi MG, Camitta B et al (2000) Outcome of treatment in children with Philadelphia chromosome–positive acute lymphoblastic leukemia. New England J Med 342:998–1006. https://doi.org/10.1056/NEJM200004063421402

3. Aricò M, Schrappe M, Hunger SP et al (2010) Clinical outcome of children with newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia treated between 1995 and 2005. J Clin Oncol 28:4755–4761. https://doi.org/10.1200/JCO.2010.30.1325

4. Schultz KR, Bowman WP, Aledo A et al (2009) Improved early event-free survival with imatinib in Philadelphia chromosome–positive acute lymphoblastic leukemia: a children’s oncology group study. J Clin Oncol 27:5175–5181. https://doi.org/10.1200/JCO.2008.21.2514

5. Biondi A, Schrappe M, de Lorenzo P et al (2012) Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study. Lancet Oncol 13:936–945. https://doi.org/10.1016/S1470-2045(12)70377-7